Lilly Research Laboratories—Dedication

Were Eli Lilly Unaware of This Study?

Richard Hockey Because of the nature of the analysis used in this study [1], no conclusion is possible. There are plenty of examples in the literature demonstrating the “ecological fallacy”. Studies such as this have very little utility other than to generate hypotheses. I tend to think that this association is a marker for greater recognition and treatment for depression. However, it’s a brave...

Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.

Dr. Milstein is the chief physician at Mercer Health and Benefits and medical director of the Pacific Business Group on Health — both in San Francisco. Dr. Smith is the president and chief executive officer of the California HealthCare Foundation, Oakland, CA. Wachter RM. The “dis-location” of U.S. medicine — the implications of medical outsourcing. N Engl J Med 2006;354:661-5. The globalizatio...

Lilly Lecture 2002 Islet Transplantation: A Brave New World

It has indeed been a distinct honor to be the recipient of the 2002 Outstanding Scientific Achievement Award, and I was happy to accept it, on behalf of the entire islet transplant field, as there have been many surgeons, physicians, and scientists who have worked as a team, moving this field forward. I was born the year the Lilly Lecture was established, 1957, and since then, this is the first...

Lilly v. Virginia Glimmers of Hope for the Confrontation Clause?

Comments of Eli Lilly and Company on the Revised Interim Written Description Guidelines

Eli Lilly and Company (" Lilly ") is pleased to offer the following comments regarding the Patent and Trademark Office's ("PTO's") recently published Revised Interim Guidelines for Examination of Patent Applications Under the 35 U.S.C. Sec. 112, ¶ 1 "Written Description" Requirement (" the Guidelines ") and the accompanying training materials entitled Synopsis of Application of Written Descript...